Related Experiment Videos
Development of a highly sensitive radioimmunoassay for digoxin and its application in pediatric practice
Insights
New sensitive digoxin radioimmunoassay methods allow rapid testing in neonates and children using minimal blood samples. Infants show a higher tolerance to digoxin levels than older children, indicating potential differences in sensitivity.
Area of Science:
- Pediatric Pharmacology
- Clinical Chemistry
- Immunoassay Development
Background:
- Digoxin is a crucial medication for treating heart conditions in pediatric patients.
- Conventional radioimmunoassay methods for digoxin require larger blood volumes, posing challenges for neonates and small children.
- Enhanced sensitivity in digoxin assays is needed for accurate therapeutic drug monitoring in infants.
Purpose of the Study:
- To develop and validate highly sensitive digoxin radioimmunoassay methods for pediatric use.
- To enable rapid and minimally invasive digoxin level determination in neonates and young children.
- To investigate potential differences in digoxin sensitivity between infants and older children.
Main Methods:
- Utilized 125I- or 3H-labelled digoxin with a rabbit antiserum against a digoxin: bovine serum albumin conjugate.
- Employed micro-volumes of plasma (10 or 25 microliters) from capillary blood samples (heel-prick).
- Compared results with conventional radioimmunoassay methods requiring larger sample volumes.
Main Results:
- Achieved increased sensitivity in routine digoxin radioimmunoassay methods.
- Demonstrated close correlation between results from sensitive assays and conventional methods.
- Identified a higher tolerance to digoxin plasma levels in infants (mean 2.6 +/- 1.8 ng/ml) compared to children over 1 year old.
Conclusions:
- The enhanced digoxin assays provide a rapid, atraumatic service for pediatric patients.
- Infants may tolerate higher digoxin plasma concentrations without toxicity compared to older individuals.
- These findings necessitate careful consideration of age-specific digoxin dosing and monitoring in pediatric care.
Abstract:
The sensitivity of two established routine digoxin radioimmunoassay methods has been increased to enable the provision of a rapid and relatively atraumatic inpatient and outpatient service for neonates and small children, using capillary blood samples obtained by heel-prick. The methods employ 125I- or 3H-labelled digoxin, a rabbit antiserum raised against a digoxin: bovine serum albumin conjugate and only 10 or 25 microliter of plasma as the sample. The results obtained using these highly sensitive assays correlate closely with those found using conventional assays, requiring larger sample volumes. An apparent difference in sensitivity to digoxin has been demonstrated between infants and children more than 1 yr old. Thus infants appear to tolerate plateau phase plasma levels (mean value for non toxic infants 2.6 +/- 1.8 ng/ml) that in older children or adults would be associated with digoxin toxicity.